Frontotemporal dementia: a systematic review of artificial intelligence approaches in differential diagnosis DOI Creative Commons
Serena Dattola, Augusto Ielo, Giuseppe Varone

и другие.

Frontiers in Aging Neuroscience, Год журнала: 2025, Номер 17

Опубликована: Апрель 10, 2025

Frontotemporal dementia (FTD) is a neurodegenerative disorder characterized by progressive degeneration of the frontal and temporal lobes, leading to significant changes in personality, behavior, language abilities. Early accurate differential diagnosis between FTD, its subtypes, other dementias, such as Alzheimer's disease (AD), crucial for appropriate treatment planning patient care. Machine learning (ML) techniques have shown promise enhancing diagnostic accuracy identifying complex patterns clinical neuroimaging data that are not easily discernible through conventional analysis. This systematic review, following PRISMA guidelines registered PROSPERO, aimed assess strengths limitations current ML models used differentiating FTD from neurological disorders. A comprehensive literature search 2013 2024 identified 25 eligible studies involving 6,544 patients with dementia, including 2,984 3,437 AD, 103 mild cognitive impairment (MCI) 20 Parkinson's or probable Lewy bodies (PDD/DLBPD). The review found Support Vector Machines (SVMs) were most frequently technique, often applied electrophysiological data. Deep methods, particularly convolutional neural networks (CNNs), also been increasingly adopted, demonstrating high distinguishing dementias. integration multimodal data, neuroimaging, EEG signals, neuropsychological assessments, has suggested enhance accuracy. showed strong potential improving diagnosis, but challenges like small sample sizes, class imbalance, lack standardization limit generalizability. Future research should prioritize development standardized protocols, larger datasets, explainable AI facilitate ML-based tools into real-world practice. https://www.crd.york.ac.uk/PROSPERO/view/CRD42024520902.

Язык: Английский

Innate immune activation in neurodegenerative diseases DOI
Sergio Castro‐Gomez, Michael T. Heneka

Immunity, Год журнала: 2024, Номер 57(4), С. 790 - 814

Опубликована: Апрель 1, 2024

Язык: Английский

Процитировано

29

A Novel CNN-Based Framework for Alzheimer’s Disease Detection Using EEG Spectrogram Representations DOI Open Access
Kostas Stefanou, Katerina D. Tzimourta, Christos Bellos

и другие.

Journal of Personalized Medicine, Год журнала: 2025, Номер 15(1), С. 27 - 27

Опубликована: Янв. 14, 2025

Background: Alzheimer’s disease (AD) is a progressive neurodegenerative disorder that poses critical challenges in global healthcare due to its increasing prevalence and severity. Diagnosing AD other dementias, such as frontotemporal dementia (FTD), slow resource-intensive, underscoring the need for automated approaches. Methods: To address this gap, study proposes novel deep learning methodology EEG classification of AD, FTD, control (CN) signals. The approach incorporates advanced preprocessing techniques CNN FFT-based spectrograms evaluated using leave-N-subjects-out validation, ensuring robust cross-subject generalizability. Results: results indicate proposed outperforms state-of-the-art machine EEG-specific neural network models, achieving an accuracy 79.45% AD/CN 80.69% AD+FTD/CN classification. Conclusions: These highlight potential EEG-based models early screening, enabling more efficient, scalable, accessible diagnostic tools.

Язык: Английский

Процитировано

4

Mitochondrial Permeability Transition, Cell Death and Neurodegeneration DOI Creative Commons
Artyom Y. Baev, Andrey Y. Vinokurov, Elena Potapova

и другие.

Cells, Год журнала: 2024, Номер 13(7), С. 648 - 648

Опубликована: Апрель 8, 2024

Neurodegenerative diseases are chronic conditions occurring when neurons die in specific brain regions that lead to loss of movement or cognitive functions. Despite the progress understanding mechanisms this pathology, currently no cure exists treat these types diseases: for some them only help is alleviating associated symptoms. Mitochondrial dysfunction has been shown be involved pathogenesis most neurodegenerative disorders. The fast and transient permeability mitochondria (the mitochondrial transition, mPT) an initial step mechanism apoptotic necrotic cell death, which acts as a regulator tissue regeneration postmitotic it leads irreparable cells function. In study, we review role transition neuronal death major diseases, covering inductors mPTP opening neurons, including ones—free radicals calcium—and discuss perspectives difficulties development neuroprotective strategy based on inhibition

Язык: Английский

Процитировано

18

Navigating the dementia landscape: Biomarkers and emerging therapies DOI

Shubhrat Maheshwari,

Aditya Singh, Valeed Ahmad Ansari

и другие.

Ageing Research Reviews, Год журнала: 2024, Номер 94, С. 102193 - 102193

Опубликована: Янв. 10, 2024

Язык: Английский

Процитировано

16

Molecular Biomarkers of Neurodegenerative Disorders: A Practical Guide to Their Appropriate Use and Interpretation in Clinical Practice DOI Open Access
Luisa Agnello, Caterina Maria Gambino, Anna Maria Ciaccio

и другие.

International Journal of Molecular Sciences, Год журнала: 2024, Номер 25(8), С. 4323 - 4323

Опубликована: Апрель 13, 2024

Neurodegenerative disorders (NDs) represent a group of different diseases characterized by the progressive degeneration and death nervous system's cells. The diagnosis is challenging, especially in early stages, due to no specific clinical signs symptoms. In this context, laboratory medicine could support clinicians detecting differentiating NDs. Indeed, biomarkers indicate pathological mechanisms underpinning ideal biofluid for NDs cerebrospinal fluid (CSF), which has limitations, hampering its widespread use practice. However, intensive efforts are underway introduce high-sensitivity analytical methods detect ND alternative nonivasive biofluid, such as blood or saliva. This study presents an overview molecular currently used For some diseases, Alzheimer's disease multiple sclerosis, well established recommended guidelines. most NDs, research ongoing identify reliable biomarkers, consensus yet been achieved.

Язык: Английский

Процитировано

13

Endo-lysosomal dysfunction in neurodegenerative diseases: opinion on current progress and future direction in the use of exosomes as biomarkers DOI Creative Commons

Mathieu Herman,

Grace W. Randall,

Julia L. Spiegel

и другие.

Philosophical Transactions of the Royal Society B Biological Sciences, Год журнала: 2024, Номер 379(1899)

Опубликована: Фев. 19, 2024

Over the past two decades, increased research has highlighted connection between endosomal trafficking defects and neurodegeneration. The endo-lysosomal network is an important, complex cellular system specialized in transport of proteins, lipids, other metabolites, essential for cell homeostasis. Disruption this pathway linked to a wide range neurodegenerative diseases, including Alzheimer's disease, Parkinson's amyotrophic lateral sclerosis, Huntington's disease frontotemporal dementia. Furthermore, there strong evidence that create opportunities diagnostic therapeutic intervention. In

Язык: Английский

Процитировано

10

Amyloid-induced neurodegeneration: A comprehensive review through aggregomics perception of proteins in health and pathology DOI
Sania Bashir,

Ayesha Aiman,

Mohammad Shahid

и другие.

Ageing Research Reviews, Год журнала: 2024, Номер 96, С. 102276 - 102276

Опубликована: Март 16, 2024

Язык: Английский

Процитировано

10

The Contribution of Functional Near-Infrared Spectroscopy (fNIRS) to the Study of Neurodegenerative Disorders: A Narrative Review DOI Creative Commons
Ioannis Liampas,

Freideriki Danga,

Panagiota Kyriakoulopoulou

и другие.

Diagnostics, Год журнала: 2024, Номер 14(6), С. 663 - 663

Опубликована: Март 21, 2024

Functional near-infrared spectroscopy (fNIRS) is an innovative neuroimaging method that offers several advantages over other commonly used modalities. This narrative review investigated the potential contribution of this to study neurodegenerative disorders. Thirty-four studies involving patients with Alzheimer’s disease (AD), mild cognitive impairment (MCI), frontotemporal dementia (FTD), Parkinson’s (PD), or amyotrophic lateral sclerosis (ALS) and healthy controls were reviewed. Overall, it was revealed prefrontal cortex individuals MCI may engage compensatory mechanisms support declining brain functions. A rightward shift suggested compensate for loss left capacity in course decline. In parallel, some reported failure early AD; lack appropriate hemodynamic responses serve as biomarker neurodegeneration. One article assessing FTD demonstrated a heterogeneous cortical activation pattern compared AD, indicating fNIRS contribute challenging distinction these conditions. Regarding PD, there evidence resources (especially executive function) recruited locomotor impairments. As ALS, data involvement extra-motor networks even absence measurable impairment.

Язык: Английский

Процитировано

10

Frontotemporal dementia. How to deal with its diagnostic complexity? DOI Creative Commons
Annibale Antonioni,

Emanuela Maria Raho,

Enrico Granieri

и другие.

Expert Review of Neurotherapeutics, Год журнала: 2025, Номер unknown

Опубликована: Фев. 6, 2025

Frontotemporal dementia (FTD) encompasses a group of heterogeneous neurodegenerative disorders. Aside from genetic cases, its diagnosis is challenging, particularly in the early stages when symptoms are ambiguous, and structural neuroimaging does not reveal characteristic patterns. The authors performed comprehensive literature search through MEDLINE, Scopus, Web Science databases to gather evidence aid diagnostic process for suspected FTD patients, phases, even sporadic ranging established promising tools. Blood-based biomarkers might help identify very neuropathological guide further evaluations. Subsequently, neurophysiological measures reflecting functional changes cortical excitatory/inhibitory circuits, along with assessing brain network, connectivity, metabolism, perfusion alterations, could detect specific associated decades before symptom onset. As advances, cognitive-behavioral profiles atrophy patterns emerge, distinguishing subtypes. Emerging disease-modifying therapies require patient enrollment. Therefore, paradigm shift needed - relying on typical cognitive advanced cases widely applicable biomarkers, primarily fluid and, subsequently, where appropriate. Additionally, exploring subjective complaints behavioral detected by home-based technologies be crucial diagnosis.

Язык: Английский

Процитировано

2

EEGConvNeXt: A Novel Convolutional Neural Network Model for Automated Detection of Alzheimer's Disease and Frontotemporal Dementia Using EEG Signals DOI

Madhav R. Acharya,

Ravinesh C. Deo, Prabal Datta Barua

и другие.

Computer Methods and Programs in Biomedicine, Год журнала: 2025, Номер 262, С. 108652 - 108652

Опубликована: Фев. 8, 2025

Язык: Английский

Процитировано

2